Entera Bio Ltd. [ENTX] has reported fiscal Q1 loss of $2.20 million.
On a per-share basis, the L3 based company said its diluted earnings are $0.08.
The Biological Products, Except Diagnostic Substances firm posted revenue of $0 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.